Market Research Logo

Allergic Rhinitis - Pipeline Review, H1 2015

Allergic Rhinitis - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Allergic Rhinitis - Pipeline Review, H1 2015’, provides an overview of the Allergic Rhinitis’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Allergic Rhinitis and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Allergic Rhinitis
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Allergic Rhinitis and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Allergic Rhinitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Allergic Rhinitis pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Allergic Rhinitis
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Allergic Rhinitis pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Allergic Rhinitis Overview
Therapeutics Development
Pipeline Products for Allergic Rhinitis - Overview
Pipeline Products for Allergic Rhinitis - Comparative Analysis
Allergic Rhinitis - Therapeutics under Development by Companies
Allergic Rhinitis - Therapeutics under Investigation by Universities/Institutes
Allergic Rhinitis - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Allergic Rhinitis - Products under Development by Companies
Allergic Rhinitis - Products under Investigation by Universities/Institutes
Allergic Rhinitis - Companies Involved in Therapeutics Development
3M Drug Delivery Systems
Adamis Pharmaceuticals Corporation
ALK-Abello A/S
AnaptysBio, Inc.
Axikin Pharmaceuticals, Inc.
BioTech Tools s.a.
ELORAC, Inc.
FAES Farma SA
Fountain Biopharma Inc.
GenMont Biotech Inc.
GlaxoSmithKline plc
Glenmark Pharmaceuticals Ltd.
GlycoMar Limited
HAL Allergy BV
Hanmi Pharmaceuticals, Co. Ltd.
Hisamitsu Pharmaceutical Co., Inc.
Johnson & Johnson
Laboratorios LETI S.L.
Ligand Pharmaceuticals, Inc.
Marinomed Biotechnologie GmbH
Merck & Co., Inc.
Mitsubishi Tanabe Pharma Corporation
Nektar Therapeutics
NeoPharm Co., Ltd.
Novartis AG
Nuvo Research Inc.
Ono Pharmaceutical Co., Ltd.
Oxagen Limited
Panmira Pharmaceuticals, LLC.
Pfizer Inc.
Protectimmun GmbH
Revance Therapeutics, Inc.
Rottapharm SpA
Shionogi & Co., Ltd.
Stallergenes S.A.
Sun Pharma Advanced Research Company Ltd.
Trimel BioPharma SRL
VentiRx Pharmaceuticals, Inc.
Xencor, Inc.
Ziarco Pharma Ltd
Allergic Rhinitis - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
(azelastine hydrochloride + mometasone furoate) - Drug Profile
(fluticasone furoate + levocabastine hydrochloride) - Drug Profile
(GSP 301-1 NS + GSP 301-2 NS) - Drug Profile
(montelukast sodium + levocetirizine dihydrochloride) - Drug Profile
854-A - Drug Profile
Allergen for Birch Pollen Induced Allergic Rhinitis and Rhinoconjunctivitis - Drug Profile
Allergen for House Dust Mites Induced Allergic Rhinitis and Rhinoconjunctivitis - Drug Profile
Allergen for Pollen Grass Allergy Induced Allergic Rhinitis and Rhinoconjunctivitis - Drug Profile
allergenic pollen extract of timothy - Drug Profile
AM-211 - Drug Profile
AM-461 - Drug Profile
ANB-020 - Drug Profile
andolast - Drug Profile
APC-3000 - Drug Profile
Arabinogalactan - Drug Profile
AVANZ Olive Immunotherapy for Allergic Rhinitis - Drug Profile
Avanz Phleum Pratense - Drug Profile
bepotastine besylate - Drug Profile
bilastine - Drug Profile
budesonide - Drug Profile
C-525 - Drug Profile
CBP-174 - Drug Profile
cidoxepin hydrochloride - Drug Profile
Depigoid Birch - Drug Profile
Dermatophagoides Pteronyssinus Allergen Extract - Drug Profile
desloratadine - Drug Profile
Drug for Japanese Cedar Pollen Allergy - Drug Profile
esketamine - Drug Profile
FB-825 - Drug Profile
fevipiprant - Drug Profile
fluticasone furoate - Drug Profile
GLY-079 - Drug Profile
GLY-145 - Drug Profile
GMNL-32 - Drug Profile
gpASIT + TM - Drug Profile
GSK-2245035 - Drug Profile
HP-3060 - Drug Profile
Lactococcus lactis G121 - Drug Profile
levocabastine hydrochloride - Drug Profile
MAM-06301 - Drug Profile
MK-8237 - Drug Profile
NKTR-125 - Drug Profile
NPB-3 - Drug Profile
OC-2417 - Drug Profile
OC-459 - Drug Profile
Olea Europaea Pollen Extract - Drug Profile
ONO-4053 - Drug Profile
PF-06444752 - Drug Profile
PF-06444753 - Drug Profile
rBet v1 - Drug Profile
rE58 - Drug Profile
RT-001 - Drug Profile
S-524101 - Drug Profile
S-555739 - Drug Profile
Small Molecule for Allergic Rhinitis - Drug Profile
Small Molecule to Antagonize G Protein Coupled Receptors for Respiratory Disorders - Drug Profile
Small Molecules to Inhibit Histamine H3 Receptor for Nasal Congestion and Allergic Rhinitis - Drug Profile
Small Molecules to Inhibit PGD2 Synthase for Asthma and Allergic Rhinitis - Drug Profile
Small Molecules to Inhibit Spleen Tyrosine Kinase for Allergic Inflammatory Disorders - Drug Profile
SUN-0597 - Drug Profile
SUNL-731 - Drug Profile
TBS-6 - Drug Profile
Vaccine for Allergic Rhinitis and Allergic Asthama - Drug Profile
VAK-694 - Drug Profile
VTX-1463 - Drug Profile
VTX-378 - Drug Profile
WF-10 - Drug Profile
WF-10 liposomal - Drug Profile
XmAb-7195 - Drug Profile
ZPL-868087 - Drug Profile
Allergic Rhinitis - Recent Pipeline Updates
Allergic Rhinitis - Dormant Projects
Allergic Rhinitis - Discontinued Products
Allergic Rhinitis - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Allergic Rhinitis, H1 2015
Number of Products under Development for Allergic Rhinitis - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Products under Development by Companies, H1 2015 (Contd..4)
Products under Development by Companies, H1 2015 (Contd..5)
Products under Investigation by Universities/Institutes, H1 2015
Allergic Rhinitis - Pipeline by 3M Drug Delivery Systems, H1 2015
Allergic Rhinitis - Pipeline by Adamis Pharmaceuticals Corporation, H1 2015
Allergic Rhinitis - Pipeline by ALK-Abello A/S, H1 2015
Allergic Rhinitis - Pipeline by AnaptysBio, Inc., H1 2015
Allergic Rhinitis - Pipeline by Axikin Pharmaceuticals, Inc., H1 2015
Allergic Rhinitis - Pipeline by BioTech Tools s.a., H1 2015
Allergic Rhinitis - Pipeline by ELORAC, Inc., H1 2015
Allergic Rhinitis - Pipeline by FAES Farma SA, H1 2015
Allergic Rhinitis - Pipeline by Fountain Biopharma Inc., H1 2015
Allergic Rhinitis - Pipeline by GenMont Biotech Inc., H1 2015
Allergic Rhinitis - Pipeline by GlaxoSmithKline plc, H1 2015
Allergic Rhinitis - Pipeline by Glenmark Pharmaceuticals Ltd., H1 2015
Allergic Rhinitis - Pipeline by GlycoMar Limited, H1 2015
Allergic Rhinitis - Pipeline by HAL Allergy BV, H1 2015
Allergic Rhinitis - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H1 2015
Allergic Rhinitis - Pipeline by Hisamitsu Pharmaceutical Co., Inc., H1 2015
Allergic Rhinitis - Pipeline by Johnson & Johnson, H1 2015
Allergic Rhinitis - Pipeline by Laboratorios LETI S.L., H1 2015
Allergic Rhinitis - Pipeline by Ligand Pharmaceuticals, Inc., H1 2015
Allergic Rhinitis - Pipeline by Marinomed Biotechnologie GmbH, H1 2015
Allergic Rhinitis - Pipeline by Merck & Co., Inc., H1 2015
Allergic Rhinitis - Pipeline by Mitsubishi Tanabe Pharma Corporation, H1 2015
Allergic Rhinitis - Pipeline by Nektar Therapeutics, H1 2015
Allergic Rhinitis - Pipeline by NeoPharm Co., Ltd., H1 2015
Allergic Rhinitis - Pipeline by Novartis AG, H1 2015
Allergic Rhinitis - Pipeline by Nuvo Research Inc., H1 2015
Allergic Rhinitis - Pipeline by Ono Pharmaceutical Co., Ltd., H1 2015
Allergic Rhinitis - Pipeline by Oxagen Limited, H1 2015
Allergic Rhinitis - Pipeline by Panmira Pharmaceuticals, LLC., H1 2015
Allergic Rhinitis - Pipeline by Pfizer Inc., H1 2015
Allergic Rhinitis - Pipeline by Protectimmun GmbH, H1 2015
Allergic Rhinitis - Pipeline by Revance Therapeutics, Inc., H1 2015
Allergic Rhinitis - Pipeline by Rottapharm SpA, H1 2015
Allergic Rhinitis - Pipeline by Shionogi & Co., Ltd., H1 2015
Allergic Rhinitis - Pipeline by Stallergenes S.A., H1 2015
Allergic Rhinitis - Pipeline by Sun Pharma Advanced Research Company Ltd., H1 2015
Allergic Rhinitis - Pipeline by Trimel BioPharma SRL, H1 2015
Allergic Rhinitis - Pipeline by VentiRx Pharmaceuticals, Inc., H1 2015
Allergic Rhinitis - Pipeline by Xencor, Inc., H1 2015
Allergic Rhinitis - Pipeline by Ziarco Pharma Ltd, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Allergic Rhinitis Therapeutics - Recent Pipeline Updates, H1 2015
Allergic Rhinitis - Dormant Projects, H1 2015
Allergic Rhinitis - Dormant Projects (Contd..1), H1 2015
Allergic Rhinitis - Dormant Projects (Contd..2), H1 2015
Allergic Rhinitis - Dormant Projects (Contd..3), H1 2015
Allergic Rhinitis - Dormant Projects (Contd..4), H1 2015
Allergic Rhinitis - Dormant Projects (Contd..5), H1 2015
Allergic Rhinitis - Dormant Projects (Contd..6), H1 2015
Allergic Rhinitis - Discontinued Products, H1 2015
Allergic Rhinitis - Discontinued Products (Contd..1), H1 2015
List of Figures
Number of Products under Development for Allergic Rhinitis, H1 2015
Number of Products under Development for Allergic Rhinitis - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report